Tenaya Therapeutics (TNYA) Stock Statistics & Valuation Metrics

Tenaya Therapeutics has a market cap or net worth of $185.99M. The enterprise value is $53.08M.

Tenaya Therapeutics has 216,998,870 shares outstanding. The number of shares has decreased by -2.65% in one year.

Tenaya Therapeutics’s return on equity (ROE) is -0.73 and return on invested capital (ROIC) is -69.39%.

The current PE Ratio of Tenaya Therapeutics is ―. Tenaya Therapeutics’s PEG ratio is 0.02.

In the last 12 months, Tenaya Therapeutics had revenue of 0.00 and earned -90.60M in profits. Earnings per share was -0.59.

In the last 12 months, operating cash flow was -68.26M and capital expenditures -618.00K, giving a free cash flow of -68.88M billion.

Tenaya Therapeutics pays an annual dividend of ―, resulting in a dividend yield of ―

Tenaya Therapeutics upcoming earnings date is May 13, 2026, After Close (Confirmed).

Tenaya Therapeutics as a current ratio of 6.84, with Debt / Equity ratio of 8.79%

In the past 12 months, Tenaya Therapeutics has paid 0.00 in taxes.

Tenaya Therapeutics EV to EBITDA ratio is -0.23, with an EV/FCF ratio of -0.28.

Tenaya Therapeutics has $100.55M in cash and marketable securities with $10.83M in debt, giving a net cash position of $89.72M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Tenaya Therapeutics is $3.83, which is 11.43% higher than the current price. The consensus rating is Strong Buy